PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29158210-8	2018	The UGT2B10 phenotype ratio (nicotine glucuronide/nicotine) was higher at early and late pregnancy compared with postpartum (P = 0.07 and P < 0.05, respectively) and correlated with a second UGT2B10 phenotype ratio (cotinine glucuronide/cotinine) (all P < 0.001), suggesting UGT2B10 activity is induced during pregnancy.	nicotine N-glucuronide	29-49	UDP glucuronosyltransferase family 2 member B10	Homo sapiens	4-11	
29158210-8	2018	The UGT2B10 phenotype ratio (nicotine glucuronide/nicotine) was higher at early and late pregnancy compared with postpartum (P = 0.07 and P < 0.05, respectively) and correlated with a second UGT2B10 phenotype ratio (cotinine glucuronide/cotinine) (all P < 0.001), suggesting UGT2B10 activity is induced during pregnancy.	nicotine N-glucuronide	29-49	UDP glucuronosyltransferase family 2 member B10	Homo sapiens	194-201	
29158210-8	2018	The UGT2B10 phenotype ratio (nicotine glucuronide/nicotine) was higher at early and late pregnancy compared with postpartum (P = 0.07 and P < 0.05, respectively) and correlated with a second UGT2B10 phenotype ratio (cotinine glucuronide/cotinine) (all P < 0.001), suggesting UGT2B10 activity is induced during pregnancy.	nicotine N-glucuronide	29-49	UDP glucuronosyltransferase family 2 member B10	Homo sapiens	194-201	
21497036-0	2011	Liquid chromatography-tandem mass spectrometry method for measurement of nicotine N-glucuronide: a marker for human UGT2B10 inhibition.	nicotine N-glucuronide	73-95	UDP glucuronosyltransferase family 2 member B10	Homo sapiens	116-123